Tethis is developing innovative solutions for liquid biopsy, a non-invasive blood test that can detect traces of tumor circulating in the blood. T ...

Enea TECH and Biomedical Foundation announces a ?15 million investment in Tethis S.p.A., a Milan-based company at the forefront of cancer ...

A groundbreaking study from the University of St Andrews School of Medicine has shown that biomarker testing in individuals ...

Guardant Health has reported preliminary full-year 2024 revenues of $737m, reflecting year-over-year (YOY) growth of 31%, ...

Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, today announced a proposed ...

In a report released yesterday, Michael Ryskin from Bank of America Securities maintained a Buy rating on Guardant Health (GH – Research ...

Previous meetings have focused on Immuno-Oncology, AI/Data Science in Oncology and Liquid Biopsy. The first meeting took ...

Dana-Farber Cancer Institute and Gustave Roussy (Grand Paris, Villejuif, France) have announced that the Fourth Transatlantic ...

PR Manager, Advanced Genomics APAC ADVANCED GENOMICS APAC Co., Ltd. ...

Millions of moms know the struggles of breast pumping: discomfort, inefficiency, and the constant battle to hold everything in place. But a revolutionary solution is gaining national attention, and ...